Reuters logo
BRIEF-Imprimis Pharmaceuticals to offer compounded Cyclosporine alternative to Restasis
2017年10月19日 / 中午11点56分 / 1 个月前

BRIEF-Imprimis Pharmaceuticals to offer compounded Cyclosporine alternative to Restasis

Oct 19 (Reuters) - Imprimis Pharmaceuticals Inc

* Imprimis Pharmaceuticals-‍making compounded Cyclosporine-based formulations available for physicians to consider prescribing as alternatives to Restasis​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below